374 related articles for article (PubMed ID: 8922571)
21. Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.
Pichichero ME; Mclinn SE; Gooch WM; Rodriguez W; Goldfarb J; Reidenberg BE
Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S102-7. PubMed ID: 7567309
[TBL] [Abstract][Full Text] [Related]
22. Penicillin V four times daily for five days versus three times daily for 10 days in patients with pharyngotonsillitis caused by group A streptococci: randomised controlled, open label, non-inferiority study.
Skoog Ståhlgren G; Tyrstrup M; Edlund C; Giske CG; Mölstad S; Norman C; Rystedt K; Sundvall PD; Hedin K
BMJ; 2019 Oct; 367():l5337. PubMed ID: 31585944
[TBL] [Abstract][Full Text] [Related]
23. Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children.
Pichichero ME; Gooch WM; Rodriguez W; Blumer JL; Aronoff SC; Jacobs RF; Musser JM
Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1053-60. PubMed ID: 7921095
[TBL] [Abstract][Full Text] [Related]
24. Two dosages of clarithromycin for five days, amoxicillin/clavulanate for five days or penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.
Syrogiannopoulos GA; Bozdogan B; Grivea IN; Ednie LM; Kritikou DI; Katopodis GD; Beratis NG; Applebaum PC;
Pediatr Infect Dis J; 2004 Sep; 23(9):857-65. PubMed ID: 15361727
[TBL] [Abstract][Full Text] [Related]
25. [Five days ceftibuten versus 10 days penicillin in the treatment of 2099 patients with A-streptococcal tonsillopharyngitis].
Adam D; Scholz H; Helmerking M
Fortschr Med Orig; 2001 Jul; 119 Suppl 2():63-70. PubMed ID: 15704358
[TBL] [Abstract][Full Text] [Related]
26. Macrolides in the management of streptococcal pharyngitis/tonsillitis.
Tarlow MJ
Pediatr Infect Dis J; 1997 Apr; 16(4):444-8. PubMed ID: 9109157
[TBL] [Abstract][Full Text] [Related]
27. Variables influencing bacteriological outcome in patients with streptococcal tonsillopharyngitis treated with penicillin V.
Ovetchkine P; Levy C; de la Rocque F; Boucherat M; Bingen E; Cohen R
Eur J Pediatr; 2002 Jul; 161(7):365-7. PubMed ID: 12111186
[TBL] [Abstract][Full Text] [Related]
28. Cefetamet pivoxil in the treatment of pharyngitis/tonsillitis in children and adults.
Guggenbichler JP
Drugs; 1994; 47 Suppl 3():27-33; discussion 34. PubMed ID: 7518764
[TBL] [Abstract][Full Text] [Related]
29. Loracarbef (LY163892) vs. penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis.
Disney FA; Hanfling MJ; Hausinger SA
Pediatr Infect Dis J; 1992 Aug; 11(8 Suppl):S20-6. PubMed ID: 1513608
[TBL] [Abstract][Full Text] [Related]
30. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group.
Nemeth MA; McCarty J; Gooch WM; Henry D; Keyserling CH; Tack KJ
Clin Ther; 1999 Nov; 21(11):1873-81. PubMed ID: 10890259
[TBL] [Abstract][Full Text] [Related]
31. Short versus standard duration antibiotic therapy for acute streptococcal pharyngitis in children.
Altamimi S; Khalil A; Khalaiwi KA; Milner R; Pusic MV; Al Othman MA
Cochrane Database Syst Rev; 2009 Jan; (1):CD004872. PubMed ID: 19160243
[TBL] [Abstract][Full Text] [Related]
32. Comparative efficacy and safety of cefprozil versus penicillin, cefaclor and erythromycin in the treatment of streptococcal pharyngitis and tonsillitis.
McCarty JM
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):846-50. PubMed ID: 7889958
[TBL] [Abstract][Full Text] [Related]
33. A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A beta-haemolytic streptococci.
Carbon C; Chatelin A; Bingen E; Zuck P; Rio Y; Guetat F; Orvain J
J Antimicrob Chemother; 1995 Jun; 35(6):843-54. PubMed ID: 7559195
[TBL] [Abstract][Full Text] [Related]
34. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America.
Bisno AL; Gerber MA; Gwaltney JM; Kaplan EL; Schwartz RH;
Clin Infect Dis; 2002 Jul; 35(2):113-25. PubMed ID: 12087516
[No Abstract] [Full Text] [Related]
35. Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children.
Pichichero ME; Casey JR; Block SL; Guttendorf R; Flanner H; Markowitz D; Clausen S
Antimicrob Agents Chemother; 2008 Jul; 52(7):2512-20. PubMed ID: 18332170
[TBL] [Abstract][Full Text] [Related]
36. 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Adam D; Hostalek U; Tröster K
Infection; 1995; 23 Suppl 2():S83-6. PubMed ID: 8537138
[TBL] [Abstract][Full Text] [Related]
37. Comparison of oral cefpodoxime proxetil and penicillin V potassium in the treatment of group A streptococcal pharyngitis/tonsillitis. The Cefpodoxime Pharyngitis Study Group.
Brown RJ; Batts DH; Hughes GS; Greenwald CA
Clin Ther; 1991; 13(5):579-88. PubMed ID: 1799915
[TBL] [Abstract][Full Text] [Related]
38. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population.
McCarty J
Am J Med; 1992 Jun; 92(6A):74S-79S. PubMed ID: 1621750
[TBL] [Abstract][Full Text] [Related]
39. Antibacterial therapy for acute group a streptococcal pharyngotonsillitis: short-course versus traditional 10-day oral regimens.
Brook I
Paediatr Drugs; 2002; 4(11):747-54. PubMed ID: 12390046
[TBL] [Abstract][Full Text] [Related]
40. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
